Merck is halting work on two potential COVID-19 vaccines following poor results in early-stage studies.The drugmaker said it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.
Merck giving up on two potential COVID-19 vaccines after poor test results
Chicago Tribune - 25 Jan 2021 15:32
Merck is halting work on two potential COVID-19 vaccines following poor results in early-stage studies.The drugmaker said it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.
Share this Article
Recommended